4-((4-Methyl-1-piperazinyl)methyl)benzoic acid dihydrochloride

4-((4-Methyl-1-piperazinyl)methyl)benzoic acid dihydrochloride is used mainly as a crucial pharmaceutical intermediate in the synthesis of the anti-cancer drug Imatinib (Gleevec), a targeted therapy for certain leukemias and gastrointestinal stromal tumors, serving as a key building block in complex drug manufacturing.

API Name Imatinib
CAS No 106261-49-8
Molecular Formula C13H20Cl2N2O2
Molecular Weight 307.21 g/mol
Synonyms 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid;dihydrochloride

Frequently Asked Questions